NCT07185139

MSCohi-O Lenses for Ocular Involvement in Sjögren's Syndrome

Exploratory Clinical Trial of MSCohi-O Lenses for Ocular Involvement in Sjögren's Syndrome

• Status: Not Yet Recruiting
• Phase: EARLY_Phase 1
• Study type: Interventional
• Enrollment: 12 (estimated)
• Sponsor: Guangdong ProCapZoom Biosciences Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

This study is aSingle-center, multiple-dosing, prospective, nonrandom, single-arm trial.

Detailed description

This study is aSingle-center, multiple-dosing, prospective, nonrandom, single-arm trial. To evaluate the clinical safety and efficacy of MSCohi-O Lenses in patients with ocular involvement of Sjögren's syndrome.

Conditions

• Sjögren's Syndrome

Interventions

Type	Name	Description
DRUG	MSCohi-O Lenses	Each subject will wear MSCohi-O Lenses for 12 hours a day, totally 14 wearings.

Timeline

• Start date: 2025-09-12
• Primary completion: 2026-08-30
• Completion: 2026-09-30
• First posted: 2025-09-22
• Last updated: 2025-09-22